"Ribonucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
Below are MeSH descriptors whose meaning is more general than "Ribonucleosides".
Below are MeSH descriptors whose meaning is more specific than "Ribonucleosides".
This graph shows the total number of publications written about "Ribonucleosides" by people in this website by year, and whether "Ribonucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Ribonucleosides" by people in Profiles.
Abdalla M, Sabbineni H, Prakash R, Ergul A, Fagan SC, Somanath PR. The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFß-induced pulmonary fibrosis. Br J Pharmacol. 2015 Aug; 172(16):4173-88.
Newman MF, Ferguson TB, White JA, Ambrosio G, Koglin J, Nussmeier NA, Pearl RG, Pitt B, Wechsler AS, Weisel RD, Reece TL, Lira A, Harrington RA. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA. 2012 Jul 11; 308(2):157-64.
Catapano CV, Dayton JS, Mitchell BS, Fernandes DJ. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol Pharmacol. 1995 May; 47(5):948-55.
Gruber SA, Erdmann GR, Burke BA, Moss A, Bowers L, Hrushesky WJ, Cipolle RJ, Canafax DM, Matas AJ. Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression. Transplantation. 1992 Jan; 53(1):12-9.